BB Biotech AG BION
The next BB Biotech AG dividend is expected to go ex in 5 months and to be paid in 5 months.
The previous BB Biotech AG dividend was 340c and it went ex 7 months ago and it was paid 7 months ago.
There is typically 1 dividend per year (excluding specials).
|Summary||Previous dividend||Next dividend|
|Per share||340c||Sign Up Required|
|Declaration date||20 Jan 2020 (Mon)||15 Jan 2021 (Fri)|
|Ex-div date||23 Mar 2020 (Mon)||18 Mar 2021 (Thu)|
|Pay date||25 Mar 2020 (Wed)||22 Mar 2021 (Mon)|
Enter the number of BB Biotech AG shares you hold and we'll calculate your dividend payments:
Sign up for BB Biotech AG and we'll email your payment info when their dividends are declared.
Add BB Biotech AG to receive free notifications when they declare their dividends.
Your account is set up to receive BB Biotech AG notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|Forecast||Final||13 Jan 2023||16 Mar 2023||20 Mar 2023||CHF||Sign up||—|
|Forecast||Final||14 Jan 2022||17 Mar 2022||21 Mar 2022||CHF||Sign up||—|
|Forecast||Final||15 Jan 2021||18 Mar 2021||22 Mar 2021||CHF||Sign up||—|
|Paid||Final||20 Jan 2020||23 Mar 2020||25 Mar 2020||CHF||310c||340c||😊|
|Paid||Final||23 Jan 2019||25 Mar 2019||27 Mar 2019||CHF||—||305c|
|Paid||Final||23 Jan 2018||15 Mar 2018||19 Mar 2018||CHF||—||330c|
|Paid||Final||20 Jan 2017||20 Mar 2017||22 Mar 2017||CHF||—||275c|
|Paid||Special||27 Feb 2016||21 Mar 2016||23 Mar 2016||CHF||—||1225c|
|Paid||Final||19 Feb 2016||21 Mar 2016||23 Mar 2016||CHF||—||225c|
|Paid||Special||26 Jan 2015||20 Mar 2015||24 Mar 2015||CHF||—||1160c|
|Paid||Special||27 Jan 2014||21 Mar 2014||26 Mar 2014||CHF||—||700c|
|Paid||Special||25 Feb 2013||20 Mar 2013||25 Mar 2013||CHF||—||450c|
BB Biotech AG Optimized Dividend Chart
About BB Biotech AG
BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.
- Pharmaceuticals & Biotechnology
- Share Price
- Fr.59.80 (yesterday's closing price)
- Shares in Issue
- 55 million
- Market Cap
- Market Indices